Brändli O, Langloh P, Plangger M, Dreher D
Zürcher Höhenklinik Wald.
Schweiz Med Wochenschr. 1988 Sep 17;118(37):1314-20.
453 patients aged over 40 hospitalized with severe COPD, a mean age of 66 years and mean FEV1 of 1.24 litres (49% predicted) were prospectively followed up for 5 years (341) and 10 years (195) respectively. 5-year survival was 47%, while 10-year survival was severely limited despite uniform therapy (23%). Average survival was only 4.4 years. Of the 15 prognostic factors considered, initial FEV1, body-weight, smoking behavior, diagnosis of bronchial asthma or emphysema, finding of p pulmonale and reversibility of bronchodilation had a significant influence on survival. The average decrease in FEV1 per year was only 28 ml in the surviving patients. It was lowest in those with FEV1 reversibility of more than 105 ml after bronchodilation. A maximum increase of FEV1 of more than 485 ml during the initial hospitalization, together with stopping smoking, were the next two important factors in FEV1 decrease. Mean annual NO2 concentration at home did not correlate significantly with survival and FEV1 decrease.
453例年龄超过40岁的重度慢性阻塞性肺疾病(COPD)住院患者,平均年龄66岁,平均第一秒用力呼气容积(FEV1)为1.24升(预计值的49%),分别进行了5年(341例)和10年(195例)的前瞻性随访。5年生存率为47%,而尽管采用统一治疗,10年生存率仍严重受限(23%)。平均生存期仅为4.4年。在考虑的15个预后因素中,初始FEV1、体重、吸烟行为、支气管哮喘或肺气肿的诊断、肺心病的发现以及支气管扩张的可逆性对生存有显著影响。存活患者的FEV1每年平均下降仅28毫升。在支气管扩张后FEV1可逆性超过105毫升的患者中下降幅度最小。初始住院期间FEV1最大增加超过485毫升以及戒烟,是FEV1下降的接下来两个重要因素。家中平均每年二氧化氮浓度与生存及FEV1下降无显著相关性。